Advertisement
Letter to the Editor| Volume 35, e9-e10, November 2016

Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low–moderate risk of stroke?

Published:August 27, 2016DOI:https://doi.org/10.1016/j.ejim.2016.08.022
Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low–moderate risk of stroke?
Previous ArticleRice bodies in the wrist joint
Next ArticleSensitization patterns in immigrants to Genoa: The relevance of origin
      Thromboprophylaxis for patients with coronary artery disease and atrial fibrillation (AF) is problematic when there is a low or moderate risk of stroke (CHADS2 score = 0 or 1), particularly when patients experience an acute coronary syndrome or undergo intracoronary stent implantation. Some physicians may be reluctant to prescribe oral anticoagulation (OAC) in these patients and several recent guidelines propose slightly different management in such settings [
      • Camm A.J.
      • Kirchhof P.
      • Lip G.Y.
      • Schotten U.
      • Savelieva I.
      • Ernst S.
      • et al.
      Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
      Eur Heart J. 2010; 31: 2369-2429
      ,
      • Lip G.Y.H.
      • Windecker S.
      • Huber K.
      • Kirchhof P.
      • Marin F.
      • Ten Berg J.M.
      • et al.
      Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).
      Eur Heart J. 2014; 35: 3155-3179
      ]. Our goal was to evaluate whether treatment with an OAC is appreciably beneficial in these AF patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Camm A.J.
        • Kirchhof P.
        • Lip G.Y.
        • Schotten U.
        • Savelieva I.
        • Ernst S.
        • et al.
        Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
        Eur Heart J. 2010; 31: 2369-2429
        View in Article
        • Lip G.Y.H.
        • Windecker S.
        • Huber K.
        • Kirchhof P.
        • Marin F.
        • Ten Berg J.M.
        • et al.
        Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).
        Eur Heart J. 2014; 35: 3155-3179
        View in Article
        • Ruiz-Nodar J.M.
        • Marín F.
        • Roldán V.
        • Valencia J.
        • Manzano-Fernández S.
        • Caballero L.
        • et al.
        Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?.
        Circ Cardiovasc Interv. 2012; 5: 459-466
        View in Article
        • Gao F.
        • Zhou Y.J.
        • Wang Z.J.
        • Shen H.
        • Liu X.L.
        • Nie B.
        • et al.
        Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation.
        Circ J. 2010; 74: 701-708
        View in Article
        • Rubboli A.
        • Faxon D.P.
        • Airaksinen J.K.
        • Schlitt A.
        • Marín F.
        • Bhatt D.L.
        • et al.
        The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.
        Thromb Haemost. 2014; 112: 1080-1087
        View in Article
        • Dewilde W.J.M.
        • Oirbans T.
        • Verheugt F.W.A.
        • Kelder J.C.
        • De Smet B.J.
        • Herrman J.P.
        • et al.
        Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.
        Lancet. 2013; 381: 1107-1115
        View in Article

      Article info

      Publication history

      Published online: August 27, 2016
      Accepted: August 16, 2016
      Received: August 10, 2016

      Identification

      DOI: https://doi.org/10.1016/j.ejim.2016.08.022

      Copyright

      © 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX